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1. Introduction 
At a planetary scale, the Metabolic Syndrome (MetS) is the third cause of inability after 
malnutrition and nicotinism, even higher than water shortage and sedentariness. In the 
USA, the prevalence is estimated at over 25% of the population; in Italy, it involves 
approximately 25% of men and even 27% of women (Ford et al. 2002). These are very high 
figures, corresponding to approximately 14 million affected individuals. The prevalence is 
alarming and must not be underestimated, particularly in the dental field, where more than 
one patient out of four sitting in a dentist’s chair is affected. The aetiology of periodontal 
disease has not been clarified yet, and recently the idea to consider it as a multifactor 
pathology has been developed. Cofactors such as the formation of reactive oxygen species 
(ROS), oxidative stress, lipid peroxidation, and formation of glycation end-products (AGEs) 
probably play an important role in the onset of periodontal disease (Pietropaoli et al. 2010). 
The AGEs are compounds physiologically produced by all metabolically active cells. 
However, they accumulate and cause pro-inflammatory statuses, when the cellular 
clearance fails, or in hyperglycaemic and oxidative statuses (Peppa et al. 2008). All these 
conditions can be clinically summarized as Metabolic Syndrome. 
The purpose of this literature review is to establish a relationship between two pathologies 
with very high prevalence: Metabolic Syndrome and Periodontal Diseases. 
The literature seems to have clarified that the Metabolic Syndrome involves a pro-oxidation 
status, which induces AGE formation. AGEs play a very important role in the course and 
severity of periodontal diseases.  
2. The Metabolic Syndrome 
The Metabolic Syndrome (MetS) (also known as X-syndrome, insulin-resistance syndrome, or 
Reaven’s syndrome) refers to a clinical condition involving a high cardio- cerebrovascular 
(CVD) risk, which includes a number of risk factors and symptoms of simultaneous 
appearance in individuals. These are often related to the individual’s life style (overweight, 
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sedentary habits), or existing pathological conditions (e.g. obesity and hypercholesterolemia) 
(Lakka et al. 2002). 
The studies confirm that individuals affected by Metabolic Syndrome, who do not 
dramatically change their life style, have a high mortality related to CVD (Lakka et al. 2002). 
The accepted definition of MetS, which is broadly applied at the international level, is given 
by the Third Report of the National Cholesterol Education Program (NCEP-III). According 
to the NCEP-III, a diagnosis of Metabolic Syndrome is applicable when at least 3 out of 5 of 
the following elements are identified: 
• Abdominal Obesity (abdomen circumference >102 cm in Men, >88 cm in Women)  
• Triglyceridemia ≥ 150 mg/dl  
• Plasma HDL cholesterol <40 mg/dl in Men, <50 mg/dl in Women  
• Arterial blood pressure ≥130 and/or ≥85 mm Hg  
• Fasting plasmatic glycaemia ≥110 mg/dl Expert Panel on Detection and of High Blood 
Cholesterol in Adults (2001).  
More recently (2005), the International Diabetes Federation has reviewed the diagnostic 
criteria, proposing the presence of two of the following disorders in the same patient as a 
method to identify the disease: 
• Triglyceridemia ≥150 mg/dl  
• Plasma HDL cholesterol <40 mg/dl in Men, <50 mg/dl in Women, or hypolipemizing 
treatment  
• Arterial blood pressure ≥130 and/or ≥85 mm Hg, or anti-hypertension treatment  
• Fasting plasmatic glycaemia ≥110 mg/dl (IFG stage),  
associated with waist circumference of more than 94 cm in men and 80 cm in women for 
Caucasian patients (the parameters vary, based on the patient’s ethnic group) (Alberti et al. 
2005). 
Substantially, these two definitions are the same. However, in the most recent review, the 
International Diabetes Federation associated the diagnostic factors with above-normal waist 
circumference and classified it as a required condition for diagnosis. 
Despres et al. (2000) assessed the lipid profile (total cholesterol, HDL cholesterol, triglycerides, 
plasmatic values of apolipoprotein B) and glucide profile (fasting insulin haematic values) of 
2103 male patients, aged 45-76 years, representative as a sample population of Québec. The 
analysis was carried out to determine the association between cardiovascular risk factors and 
ischemic cardiopathy during a five-year period (Després et al. 2000). During the study, 
significantly higher fasting insulinemia (p < 0.001) was observed in patients affected by 
ischemic events. The hyperinsulinemia-artherosclerotic cardiopathy association kept this high 
rate also after a correction of triglycerides, apolipoprotein B, LDL cholesterol, and HDL 
cholesterol levels. Therefore, high insulin plasmatic concentrations in non-diabetic individuals 
– who can be classified as ‘insulin-resistant’ – were associated with an ischemic cardiopathy 
increase, independently from the lipid profile (although a lipid profile alteration in pro-
atherogen sense has a synergic effect with hyperinsulinemia) (Després et al. 2000). 
In addition to the role played in glucidic metabolism, insulin contributes to regulating lipid 
and protein metabolism and arterial blood pressure, interfering with platelet function and 
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the balance between pro-thrombotic factors and endogenous fibrinolysis modulators. It also 
regulates the proliferative stimuli on smooth muscle cells of vascular walls and influences 
the endothelial function: all this explains the possible role played by insulin- resistance in 
determining the Metabolic Syndrome (Harano et al. 2002). 
The mechanisms of insulin resistance, or the insulin-cell surface-intracellular compartment 
interaction sites, in which the chain of signals produced by the hormones stops, preventing 
an appropriate use of circulating glucose, are not known yet. Insulin-resistance almost 
certainly develops much before the Metabolic Syndrome and other more advanced clinical 
diseases, such as type-2 diabetes mellitus and atherosclerosis, appearing in all contexts as a 
multifactor reality in terms of both its onset and potential harm (Harano et al. 2002). 
It is clear that, in a person affected by MetS, a hyperglycaemia status triggers cellular 
damage with repercussions at the systemic level and also on periodontal tissue. Periodontal 
diseases of diabetic origin are a clear example of this (Bensley et al. 2011). 
New studies focus on the aetiology of periodontal diseases and the role of oxidative stress, 
starting a cascade of molecular signals from inflammation mediators, which cause loss of 
attachment, reabsorption of alveolar bone, and, ultimately, tooth loss, through activation of 
osteoclasts (Pietropaoli et al. 2010). As a source of oxidative stress, the MetS could provide 
an alternative etiological explanation to the development of periodontal disease, as 
suggested by Bullon et al. (2009). 
The purpose of this study is to extend this vision, which includes the residual products of 
non-enzymatic glycosylation, originated from oxidative metabolism conditions, as factors 
promoting periodontal disease. 
3. Metabolic Syndrome and oxidative stress 
It is known that all MetS triggering factors play a clear role in the onset of oxidative stress, in 
the subsequent formation of Reactive Oxygen Species (ROS), and probably also in the 
activation of the pro-oxidising, pro-inflammatory AGE-RAGE system (Koyama et al. 2005). 
Many inflammatory pathways are activated by these conditions. The excess of visceral fat 
(high waist circumference) is certainly one of the most important factors in activating these 
signalling molecular cascades through the TNF-alfa pathway (Boden 2006). 
Visceral fat, unlike subcutaneous fat, induces lipolysis increase, when stimulated, with 
release of Free Fatty Acids (FFA) in the blood circulation. Excess FFAs significantly 
contribute to inducing hyperinsulinemia, as they reduce insulin clearance, increase hepatic 
gluconeogenesis, reduce glucose uptake in the muscle tissues, and facilitate a pro-
inflammatory status (Liu et al. 2011). 
TNF-alfa increase, in turn, contributes to triggering the molecular processes that lead to the 
development of insulin-resistance, which would apparently play a key pathogenetic role in 
all MetS conditions (Odrowaz-Sypniewska 2007). When calorie intake is higher than body 
consumption, ROS excess is created, due to hyper-activity of the citric acid cycle, hence 
oxidative stress (Maddux et al. 2001). This oxidative stress alters intracellular signalling and 
contributes to the development of insulin-resistance (Evans et al. 2003). On the other hand, 
Ceriello et al. (2000) showed that insulin-sensitivity improves after administration of anti-
oxidizing substances (Ceriello and Motz 2004). 
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Soory et al. (2009) claim that ROS increase causes a hyper-inflammation status in its most 
aggressive forms of periodontal disease and causes an unbalance of redox status, outcome of 
which is damage. In accordance with this vision, the hyper-inflammation status associated 
with periodontal disorder could overload the body with Reactive Oxygen Species, which are 
in turn able to contribute to the development of other pathologies, such as metabolic, articular, 
neoplastic, or geriatric diseases (Soory, 2009). In addition to lipid peroxidation, the AGEs are 
another emerging marker of oxidative stress. The AGEs are a set of heterogeneous products 
constantly formed in physiological conditions, but significantly increasing in the presence of 
hyperglycaemia and excessive oxidative stress (Peppa et al., 2008). The recent literature 
suggests that the AGEs are the cause of a large number of adverse conditions established in 
systemic diseases, where the oxidative component is strong, as in diabetes (Xue et al., 2011). 
The activation of these pathways is not restricted to limited areas of the body, but their 
signalling triggers systemic responses, which are also visible at the level of teeth supporting 
tissues. Since the 1970s, it is known that obesity and hypertension increase the severity of 
the periodontal disease (Perlstein and Bissada, 1977). It is also suggested that overweight 
individuals have a worse periodontal status than individuals with a normal body weight, 
with evident histological changes on dental tissues (Suvan et al., 2011). To support this 
suggestion, Pischon et al. (2007) clearly emphasised that inflammation caused by obesity 
markedly affects the status of periodontal tissues. In these cases, the activation of pro-
inflammatory cytokines has been broadly supported by scientific literature. In fact, TNF-
alfa, Interleukin-6 and -10 (IL-6, IL-10), and C-Reactive Protein (CRP) are certainly involved 
in individuals with high Body Mass Index (BMI) (Pischon et al., 2007). 
The activation of these complexes leads to the interaction between AGEs and RAGE cellular 
receptors (found in many cell populations), which amplify the release of cytokines, 
metalloproteinases (MMPs), and ROS. 
It is worth stressing that the nature of an individual’s diet certainly contributes to the action 
of inflammatory cytokines. Obese individuals eat several times during the day, without 
caring too much for oral hygiene, thus facilitating accumulation of dental plaque and dental 
calculus. This condition is the basis of periodontal problems in these subjects. 
4. Advanced Glycation End-Products (AGEs) 
The AGEs are a heterogeneous group of physiologically formed compounds, which 
accumulate when cellular clearance fails, and in hyperglycaemia and oxidative stress 
conditions (Peppa et al., 2008). 
The accumulation of AGEs may also be dependent on environmental sources, such as 
tobacco smoking (Yamagishi et al., 2008), vegetarian diet (Sebeková et al., 2006), alcohol 
(Kalousová et al., 2004), consumption of browned foods, and high lipid/glucide quantities 
(Krajcovicová-Kudlácková et al., 2002). Approximately one third of AGEs intake through 
diet is excreted with urine, whereas the remaining part is supposedly incorporated in tissues 
(Bohlender et al., 2005). 
These compounds are produced through enzymatic pathway from monosaccharide 
substances, such as glucose and fructose, but also dicarbonyls originating from Maillard’s 
reaction, sugar self-oxidation, and other molecular pathways, such as glycolysis, which 
involves the formation of glyoxal and methylglyoxal (Fu et al., 1996).The non-enzymatic 
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post-translational glycosilations of proteins occur through reductive amination reaction 
between the non-reducing end of a carbohydrate and primary amino groups located on 
macromolecules containing lysine or arginine residues (amino acids, proteins, 
phospholipids, lipids, and nucleic acids). These reactions lead to the formation of a number 
of reversible intermediate products called Schiff’s bases and Amadori products (e.g. 
Glycated haemoglobin; HbA1C). Any subsequent rearrangement of these complexes lead to 
the formation of much more stable products, the AGEs, which affect the functionality and 
properties of proteins, lipids, and DNA (Thornalley, 2005; Fu et al., 1996).A key role in the 
formation of these adducts can be referred to oxidative stress and aging (Baynes, 2001). 
Oxidising conditions and Reactive Oxygen Species (ROS) facilitate the formation of AGEs, 
which in turn increase the production of free radicals (Wen et al., 2002; Yin et al., 2001). 
Schiff’s bases and Amadori products increase ROS production, and hyperglycaemia 
promotes glucose self-oxidation, which involves OH radicals (Noiri and Tsukahara, 2005). 
Several studies clearly show that the AGEs are involved in the development of diabetes 
problems, andin CVD and renal and neurodegenerative disease pathogenesis (Goldin et al., 
2006; Zhang et al., 2009). 
Throughout life, AGEs produced accumulate in the tissues and can be found in plasma 
(Ulrich and Cerami, 2001). The pathogenetic action of these compounds performs directly, 
damaging the tissues, or indirectly, binding a specific receptor, called RAGE, which belongs 
to the family of immunoglobulins (Ramasamy et al., 2005). 
This receptor is physiologically found in small quantities in many cells, but it is over-
expressed in conditions such as diabetes, vasculopathy, and cancer (Ramasamy et al., 2005). 
The AGE-RAGE bond involves a cascade of pro-inflammatory signalling with subsequent 
activation of redox-sensitive transcription factors, such as nuclear factor kappa B (NF-κB) 
(Schmidt and Stern, 2000). This interaction involves hyper-permeability, at the level of 
endothelial cells, and activates the vascular cell adhesion molecule-1 (VCAM-1) molecule, 
whereas on monocytes it involves chemotaxis and cytokine increase, such as the tumour 
necrosis factor (TNF), and interleukins IL-1 and IL-6 (Vlassara et al., 1988). Collagen 
synthesis by fibroblasts is also reduced (Hollá et al., 2001). 
In addition to persistent hyperglycaemia statuses, transient hyperglycaemia is also a risk 
condition, as it induces pro-inflammatory signalling and activates the long-lasting 
expression of p65, which is a fraction of the above-mentioned NF-κB (Siebel et al., 2010). 
Recently, the interest in this condition has grown, as a few studies report that the ‘cell 
memory’ – thus, pro-inflammatory signalling – continues up to 16 hours after the end of the 
hyperglycaemic condition (El-Osta et al., 2008). 
Long-survival proteins, such as collagen, are the most vulnerable molecules exposed to 
cross-links and forming AGEs, with subsequent subtraction to proteolysis and tissue 
remodelling (Verzijl et al., 2000). Collagen irreversibly modified by the AGEs is also the 
vascular collagen, which contributes to the formation of atherosclerosis and development of 
kidney failure (Bohlender et al., 2005). The AGEs have a higher predictive value of 
microvascular complication development than the value of other risk predictors, such as the 
duration of diabetes and HbA1c. 
On the other hand, reduced clearance of serum AGEs can further increase the accumulation 
of AGEs in tissues and their new formation, which worsens kidney failure (Miyata et al., 
1997). 
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5. Aetiology and pathogenesis of periodontitis 
The aetiology of periodontitis has not been fully clarified yet. However, it is commonly 
accepted that it may result from an opportunistic infection. The bacteria cross the epithelial 
barrier and invade the sub-epithelial connective tissue. A crucial role is played by the 
increase in the number of dental plaque microorganisms, their capacity to penetrate the 
tissues, and the host’s immunological status. The damage is only partially reversible, even 
after professional treatment (Needleman et al., 2006). 
The hyper-inflammation following these events determines the failure of the immunological 
response: it does not only remove the pathogens, but it also involves the prolonged release 
of proteolytic enzymes by the neutrophils, pro-inflammatory mediators, and ROS (Sheikhi 
et al., 2000). These elements determine periodontal attachment destruction (Chapple and 
Matthews, 2007). Fusobacterium nucleatum and the other oral pathogens induce an increase in 
intracellular production and ROS release in neutrophils (Sheikhi et al., 2000). Higher ROS 
levels are, in fact, found in saliva and gingival crevicular fluid of patients with chronic 
periodontitis as compared with healthy controls (Tsai et al., 2005). 
Lee et al. (2008) suggest that hydrogen peroxide (oxygenated water) deposited in 
periodontal tissues to reduce the inflammation caused by bacteria accelerates their 
destruction by activating the IL-8 pathway in periodontal cells (Lee et al., 2008). This event 
should not be underestimated and should be taken into consideration during periodontal 
surgery. 
Soory et al. (2009) proposed that during periodontal disease, increased ROS production may 
worsen an inflammatory condition, causing an alteration of the redox status and inducing 
damage from oxidative stress, which involves a more rapid evolution of the disease (Soory, 
2008). A broad body of literature documenting a link between periodontal diseases and 
other pro-oxidative inflammatory diseases support this hypothesis. In fact, it has been 
confirmed that diseases inducing oxidative metabolic changes, such as diabetes, arthritis, 
neoplasias, and aging, are associated with periodontal disease, increasing its severity (Soory, 
2009). 
Based on these observations, it is clear that many conditions may worsen periodon- tal 
disorders or promote new onset. Contemporary literature supports the assumption that, in 
addition to inflammation and oxidative stress, other conditions such as cigarette smoking 
(Bagaitkar et al., 2009), vitamin deficits, alcohol abuse, diet (Dye, 2010; Hujoel, 2009), and 
other pro-oxidation conditions, such as MetS, play a key role in the activation of signalling 
pathways, which act in promoting ROS development and probably also in worsening or 
producing new onset of a periodontal disease (Liu et al., 2011; Soory, 2009; Boden, 2006). 
SO, WHY IS METS INVOLVED IN PERIODONTAL DISEASES? 
Certainly this is because a pathological range including all pro-oxidation conditions 
(hyperglycaemia, hyperlipaemia, obesity, and hypertension), which coexist in a vicious 
circle, and establish and support the onset of free radicals and products from non-enzymatic 
glycosilation. As yet, there is not much in literature to support this assumption, except for a 
note- worthy epidemiological analysis, which helps to provide the background on the 
relationship between MetS and periodontal diseases, i.e. the analysis of the American study 
NHANES III (D’Aiuto et al., 2008). NHANES III (Third National Health and Nutrition 
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Examination Survey) analysed 13,994 individuals (men and women) aged over 17. The 
study assessed their periodontal condition through plaque and bleeding indexes, and 
testing depth, as well as the Metabolic Syndrome parameters. The patients aged over 45 
affected by MetS had a risk 2.31 times higher than healthy individuals of being affected by 
periodontal diseases. The study authors concluded that serious periodontal disease is 
associated with middle-aged individuals affected by MetS (D’Aiuto et al., 2008). Further 
investigations are required to support and extend this hypothesis. However, it is clear 
enough that the MetS negatively influences the health of tissues supporting the teeth. 
6. Metabolic Syndrome, AGEs, and periodontal diseases 
Hypertension, obesity, dyslipidemia, and hyperglycaemia, which coexist in MetS, play an 
incremental role in ROS and AGEs production (Turco et al., 2011). This is probably on the 
basis of a potential MetS role in the destruction of periodontal tissues. In fact, the AGEs 
create damage by directly modifying proteins (Verzijl et al., 2000), or indirectly, activating 
signalling through its RAGE receptors (Schmidt et al., 2000). The interaction AGE-RAGE 
results in pro-inflammatory signalling and in generation of intracellular oxidative stress and 
subsequent activation of the redox-sensitive transcription factors such as NF-κB (Schmidt 
and Stern, 2000). Formation of AGEs is a way to maintain the signal of a short oxidative 
burst in a much longer-lived post translational modified proteins (Andrassy et al., 2006). 
Interaction of RAGE with AGEs in endothelial cells results in hyperpermeability and 
enhanced expression of adhesion molecules such as vascular cell adhesion molecule-1 
(VCAM-1). This interaction on monocytes induces chemotaxis, as well as an increased 
generation of cytokines such as tumour necrosis factor (TNF), interleukin-1 (IL-1), or IL-6 
(Vlassara et al., 1988). 
Furthermore, the engagement of RAGE results in diminished collagen synthesis in 
fibroblasts (Hollá et al., 2001). Recent observations suggest that RAGE is a central cell-
surface receptor also for EN-RAGE (extracellular newly identified RAGE binding proteins) 
and other members of the S100/calgranulin family of pro-inflammatory cytokines 
(Hofmann et al., 1999). These intracellular proteins may gain access to extracellular space in 
the inflammatory milieu. Upon release, their ability to interact with cellular RAGE appears 
to be an important means by which to propagate inflammatory cellular perturbation and 
chronic tissue injury (Schaefer and Heizmann, 1996). It is important to note that a study with 
diabetic rats shows that RAGE inhibition prevents the progression of periodontal disease, 
improving the prognosis, and reduces the formation of pro-inflammatory cytokines, such as 
IL-6, TNF-alfa, and metalloproteinases, significantly reducing the loss of alveolar bone 
(Schmidt et al., 1996). The authors have also observed that the beneficial effect of the RAGE 
block is independent from glycaemic control, thus supporting the importance of signalling 
RAGE in periodontal disease. Observations based on the involvement of RAGEs in 
periodontal disease are not valid to support the hypothesis that the AGEs are involved in 
the onset of periodontal disease. However, this aspect has been recently studied by Murillo 
et al. (2008) and Ren et al. (2009), who assessed the in vitro effect of AGEs on human 
gingival and periodontal fibroblasts. Both of these studies started from the premise that an 
important role in periodontal physiology is played by cell interaction with molecules of the 
extracellular matrix (Steffensen et al., 2001). In an in vitro model of periodontal cells, the 
behaviour of human gingival fibroblasts (hGFs) and human periodontal fibroblasts (hPDLs) 
is deeply influenced by changes in the surrounding environment (Lackler et al., 2000). The 
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glycated proteins of the extracellular matrix can also have their pathogenic effects 
interacting with RAGE. The observation that the AGEs can regulate the cellular function and 
hGFs’ collagen metabolism supports this assumption. It was also found that the AGEs 
reduce the mobility of these cells and significantly inhibit the expression of type I and III 
collagen (Ren et al., 2009). The importance of these mechanisms in the pathogenesis of 
periodontal disease is emphasised by the observation according to which the reduction of 
periodontal integrity, which occurs physiologically with age, could be referred to a reduced 
expression of type I collagen caused by age-dependent hypermethylation in the gene-
promoting area (Ohi et al., 2006). 
In concurrence with the above-mentioned data, it seems that the AGEs participate in the 
pathogenesis of periodontal disease, independently from the mechanisms provoking their 
accumulation. This hypothesis is supported by a recent study, which has investigated the 
existing relationship between the development of periodontal disease and glycosylated 
haemoglobin (HbA1c) levels in non-diabetic individuals. The periodontal health status, 
analysed in these patients using modified CPI (Community Periodontal Index), was 
significantly correlated with HbA1c levels. After the normalisation of data, the authors 
observed that mean HbA1c was significantly increased in the case of periodontal 
deterioration (Hayashida et al., 2009). 
7. Final considerations and future developments 
The literature analysed clearly shows that all the conditions and pathologies causing 
oxidative stress, production of AGEs, and activation of RAGE, are potentially involved in 
the aetiology and severity of periodontal diseases, and particularly in the development of 
chronic periodontitis. 
As the MetS is defined by the presence of hyperglycaemia, dyslipidemia, obesity, 
hypertension – all these conditions determine ROS increase and AGEs production – it is 
clear that the MetS may worsen an existing state, or cause a new periodontal pathology, 
with mechanisms like those described for diabetes, where the AGEs play a key role in the 
onset of microangiopathy, retinopathy, nephropathy, neuropathy, and general tissue 
degeneration conditions (Ramasamy et al., 2005). Considered individually, the conditions 
defining the MetS play an important role. However, their role is certainly at a lower level as 
compared with synergic action. It is now described by clinical evidence and scientific 
literature that neglecting a high BMI involves a cascade of other compensatory and 
dysfunctional conditions promoted by humoral signalling; whose sum defines the MetS 
(Martin-Cordero et al., 2011; Martínez-Clemente et al., 2011). 
The AGEs that may irreversibly accumulate in periodontal tissue with age, prolonged 
hyperglycaemia and/or chronic inflammation statuses, such as those that may be observed 
in the MetS, can damage the tissues and affect the functional status of collagen fibres and 
increase ROS and inflammation mediator levels through the interaction with RAGE. The 
formation of AGEs in the extracellular matrix may contribute to increasing ROS production 
and release from phagocytes and periodontal ligament cells, with subsequent induction of 
pro-inflammatory cytokines and metalloproteinases, leading to osteoclast activation and 
bone loss. 
Since AGEs are products of accumulation, all these conditions have more significance in a 
condition which needs long time to develop, just as chronic periodontitis.  
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Therefore, we believe periodontal diseases , and particularly chronic periodontitis, should 
be considered by a multidisciplinary approach, bearing in mind that the periodontal tissues 
exposed not only to local bacterial onslaught, but also to systemic conditions damaging 
them through the same mechanisms provoking damage in other tissues. 
 
Fig. 1. In this figure has been represented the hypothesis supported in this article. MetS 
promote a self supporting ROS and AGEs accumulation that result in chronic inflammation 
signalling. This condition also promotes the osteoclast activation that result in alveolar bone 
loss.  
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